Fluxergy Expands to Scale Up COVID-19 Test Production and Prepare for Testing Beyond COVID-19
Fluxergy has expanded it’s U.S. headquarters after commercializing the test globally. The expansion will enable the company to ramp up production of the rapid test as well as further develop the test platform for other uses.
Fluxergy speaks in ForbesBooks: Uncertain Times Podcast
Join Tej Patel, the President and co-founder of Fluxergy, as he talks about the current state of medical diagnostic testing, the inspiration for starting the company, and what the future of Fluxergy looks like.
How Advances in Testing are Bringing New Level of Safety to the Foodservice Industry
Being able to cost-effectively detect agents of concern like listeria, campylobacter, and salmonella within 30 minutes of sample collection allows for real-time monitoring of the product throughout its lifecycle to prevent a recall of inventory and ill effects to consumers.
How to Find a Job in the Life Sciences Industry During a Pandemic
President Tej Patel shares his insights on education and specific advice for landing a job in the life sciences during the pandemic. His team includes backgrounds in the semiconductor, aerospace, and automotive industries.
Fluxergy Seeks Commercialization Partners for CE-Marked One-Hour COVID-19 Test
Fluxergy is looking for partners to help bring its CE-marked COVID-19 test to market. The automated testing platform has multimodal capability allowing for a variety of assay types to be run simultaneously on the same cartridge.
Fluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry
IRVINE, CA., March 25, 2021 – Fluxergy, Inc., a medical diagnostic testing platform company with a detection technology solution capable of multimodality, announced today that it has obtained CE marking for its one-hour COVID-19 RT-PCR test, to use by healthcare professionals as an in vitro diagnostic (IVD) for the detection of SARS-CoV-2. The CE-mark will allow […]
Fluxergy speaks in Action and Ambition Podcast
Join President Tej Patel on a new episode of Action and Ambition. Tej shares how he leveraged his knowledge to create successful business strategies.
360 DX: Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets
The COVID-19 pandemic has shed light on the need for mass testing, particularly in areas that don’t have access to centralized laboratories or trained technicians.
Medical device developer eyeing personalized nutrition opportunities
NutraIngredients-USA spoke with Tej Patel, president and cofounder of the company Fluxergy.
Full Steam Ahead for Startups developing COVID-19 Vaccines and Products
“Initially, doctors weren’t even allowed to give tests unless they thought it was COVID,” Patel added. “In today’s world, data is so important. It’s all about technology to get this information sooner.”
Fluxergy Expands Research and Manufacturing Facility in Irvine, CA
Fluxergy’s Irvine campus will encompass over 65,000 sq. ft, as the company seeks to quickly build capacity for producing a high-speed point of care diagnostic testing system to assist in the COVID-19 pandemic response. July 20, 2020, Irvine, CA — Fluxergy LLC, has entered into an agreement to establish a new and expanded research and manufacturing […]
Fluxergy to Collaborate with Mass General Brigham to Conduct Evaluation of One-Hour COVID-19 Test
IRVINE, CA., July 2, 2020 – California-based Fluxergy will work with Mass General Brigham (MGB), a major health system in Massachusetts, to further evaluate Fluxergy’s innovative Research Use Only (RUO) COVID-19 testing platform, designed to deliver accurate PCR test results in under one hour.